Sign In
test

Casey Cwynar

Tcg Crossover Management, Llc

Assets Managed
$3.495B
Holdings
49
Last Quarter
2026 - Q1
Filed Date
19d ago
Growth Rate
15.68%(2Q avg: 32.16%)
Sustained Growth
4 quarters

Portfolio positions

This chart displays the top 10 holdings in Tcg Crossover Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 49 positions.

Assets under management

The assets under management (AUM) of Tcg Crossover Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 3.495B in assets, with a quarterly growth rate of 15.68% and a 2-quarter average growth rate of 32.16%. The portfolio is managed by Casey Cwynar, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
ABVX
Abivax Sa-adr
Recent Activity
Decreased -8.86%
20.65%
$721.669M
6.481M shares@ $111.36 avg price
CGON
Cg Oncology Inc
Recent Activity
7.11%
$248.4M
3.67M shares@ $67.68 avg price
TNGX
Tango Therapeutics Inc
Recent Activity
Decreased -17.48%
6.31%
$220.31M
10.531M shares@ $20.92 avg price
COGT
Cogent Biosciences Inc
Recent Activity
Decreased -15.69%
5.45%
$190.406M
4.947M shares@ $38.49 avg price
CNTA
Centessa Pharmaceuticals-adr
Recent Activity
4.88%
$170.259M
4.286M shares@ $39.73 avg price
DNTH
Dianthus Therapeutics Inc
Recent Activity
4.03%
$140.702M
1.677M shares@ $83.92 avg price
TYRA
Tyra Biosciences Inc
Recent Activity
Increased 12.11%
3.57%
$124.436M
3.249M shares@ $38.3 avg price
IMVT
Immunovant Inc
Recent Activity
Increased 168.41%
3.17%
$110.736M
4.458M shares@ $24.85 avg price
BCRX
Biocryst Pharmaceuticals Inc
Recent Activity
New Position
3.01%
$104.92M
11.021M shares@ $9.52 avg price
MIRM
Mirum Pharmaceuticals Inc
Recent Activity
Increased 1611.63%
2.81%
$98.112M
1.062M shares@ $92.39 avg price

1-10 of 49